Sources & guide methodology

A source has a specific role

• Ontario determines its funded programs and publishes school guidance.
• NACI recommends clinical use nationally; a recommendation does not automatically change Ontario funding.
• Federal provincial tables help identify differences or recent changes.
• Exact product ingredients and packaging belong to the current product monograph.

How the guide works

Choose an age range or Grade 7 and a situation. The timeline shows the routine visit for that stage, upcoming visits, and optional earlier and later milestones. Earlier visits do not mean doses were received. The tool does not calculate due dates or a catch-up plan. Choose Grade 7 by actual school grade, not age.

Source differences that matter

The July 2026 federal table lists ACYW meningococcal vaccine at Ontario’s 12-month and Grade 7 visits; Ontario’s routine page describes “meningococcal conjugate.” The guide uses the general description in the schedule and explains the transition on the profile.

Ontario’s school program lists two HPV doses, while national recommendations allow one for many people aged 9–20. The profile explains that difference. Ontario’s routine page says age 4 and age 14; the school page gives 4–6 and 14–16-year windows. This guide encourages booking from the starting ages.

Ontario’s 2026–2027 RSV pregnancy program uses 28–36 weeks. This differs from Health Canada’s authorized 32–36-week window; use before 32 weeks requires clinical judgment. The RSV profile explains this distinction. Current Ontario program

Limits and review status

This is a simplified educational resource. Product availability, seasonal eligibility, local appointment access and individual records still need confirmation. No independent clinical certification is claimed.